<DOC>
	<DOCNO>NCT01020747</DOCNO>
	<brief_summary>This phase I single center open label study plan assess safety tolerability bevacizumab treat patient bilateral Recurrent Respiratory Papillomatosis ( RRP ) . Approximately 20 patient receive bevacizumab directly inject vocal fold . Patients enroll protocol inject bevacizumab one vocal fold represent diseased two fold . A sham injection saline administer vocal fold control . This therapy administer every 6 ± 1 week 6 month , vocal fold select initial treatment always get drug injection . The investigator also treat lesion laser photoangiolysis vocal fold use 532 nm potassium-titanyl-phosphate ( KTP ) laser .</brief_summary>
	<brief_title>Bevacizumab Treatment Recurrent Respiratory Papillomatosis ( RRP )</brief_title>
	<detailed_description />
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Male female patient dysphonia diagnose Recurrent Respiratory Papillomatosis ( RRP ) vocal fold Age 18 60 year old Female patient must surgically sterilize , postmenopausal , employ adequate contraception . Criteria menopause surgical menopause ( hysterectomy , oophorectomy ) age &gt; 45 year absence menses great 12 month elevate serum Hormone , folliclestimulating ( FSH ) ( &gt; 25 mIU/mL ) . Tubal ligation menses within past 12 month consider surgical sterilization . Have bilateral glottal papillomatosis ( i.e. , involve right left vocal fold ) Willing able comply investigational nature study able communicate well investigator . Ability comprehend willingness provide write informed consent accordance institutional regulatory guideline . Have know sensitivity bevacizumab Have treat systemically bevacizumab within 4 month ( approximately 6 halflives ) . Have hematocrit &lt; 30 , elevate PT PTT level 1.2 X upper limit normal ( ULN ) absolute platelet count low limit normal ( LLN ) . Have absolute neutrophil count 1500 Have urine dipstick positive ≥3+ proteinuria spot urine collection patient urine protein urine creatinine ratio great 1.5 . Have history congestive heart failure , angina remain symptomatic despite medication , myocardial infarction coronary artery diseaserelated procedure within past 6 month ( include angioplasty , stent placement , bypass graft surgery ) prosthetic heart valve . Have significant uncontrolled hypertension ( systolic blood pressure 160 and/or diastolic blood pressure 100 ) . Have surgery within 1 month enrollment unhealed surgical incision screen . Have history thromboembolic event , gastrointestinal ( GI ) ulcer bleeding , history wound dehiscence . Female patient pregnant , nursing plan nurse 18 month treatment period . Patients history bleed disorder , document platelet dysfunction , current use antiplatelet drug , abnormal prothrombin time ( PT ) activate partial thromboplastin timea ( PTT ) laboratory value define number 3 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>